Summary In a prospective study of 5,004 women in Guernsey, plasma samples were collected and stored. Retinol, fl-carotene and vitamin E levels were later measured in the samples from 39 women who subsequently developed breast cancer and from 78 controls who did not develop cancer. Plasma retinol levels were not related to the risk of breast cancer, mean levels among cases and controls being 485 jigl-1 and 479,igl 1 respectively. Plasma vitamin E levels showed a clear association, low levels being associated with a significantly higher risk of cancer. The mean vitamin E levels among cases and controls were 4.7mgl-' and 6.0mgl-1 respectively (P<0.025), and the risk of breast cancer in women with vitamin E levels in the lowest quintile was about 5-times higher than the risk for women with levels in the highest quintile (P<0.01). f,-carotene levels showed a tendency to be lower in women who developed cancer than in controls (36ugl-1 among cases compared with 50 pgI-1 among controls) but the difference was not statistically significant.
The view that certain vitamins, such as vitamin A (in the form of retinol or its precursor f-carotene) and vitamin E, may protect against the risk of cancer has recently attracted much scientific attention.
Three prospective studies, all concerning men, have examined the relationship between serum retinol and subsequent risk of cancer. Two of these studies (Wald et al., 1980a,b; Kark et al., 1981) showed a statistically significant negative association between serum retinol and risk of cancer (particularly lung cancer) and the third (Stahelin et al., 1982) suggested a negative association between serum retinol and risk of stomach cancer. Studies investigating serum ,Bcarotene or serum vitamin E and subsequent risk of cancer have not been published. Epidemiological studies of diet and cancer are consistent with ,Bcarotene intake being associated with a reduced risk of cancer (Peto et al., 1981 : Shekelle et al., 1981 but the evidence is relatively non-specific as dietary factors other than #-carotene might well have been involved. There is some evidence based on experimental work on animals that both fl-carotene (Mathews-Roth, 1982) and vitamin E (Cook & McNamara, 1980) which plasma samples have been stored for future biochemical analysis. One such investigation is the ICRF prospective study in Guernsey which has been the subject of previous reports, mainly on the role of endocrine factors in the aetiology of breast cancer (Bulbrook et al., 1971; Kwa et al., 1981) . The availability of data and plasma samples from this study encouraged us to explore the possibility that low plasma concentrations of retinol, P-carotene and vitamin E might be associated with subsequent risk of breast cancer. 1968 and 1975, 5,004 women in Guernsey aged between 28 and 75 years volunteered a blood sample from which plasma was stored at -200C. Women who developed breast cancer were notified to the study by the general practitioners concerned, and this report relates to the 39 cases reported until the end of 1982 from whom plasma was available for testing.
Materials and methods

Between
Stored plasma samples from these women were retrieved and for each two controls who had previously been used in a study of hormone levels in relation to breast cancer were identified and their plasma samples also retrieved. Selection of controls in this way meant that plasma samples for cases and controls had all been frozen and thawed a similar number of times. The matching criteria were age (± 5 years), menopausal status (if premenopausal, day of menstrual cycle within 4 days; if post-menopausal, number of years postmenopausal), and a number of other factors including parity, family history of breast cancer, and previous history of benign breast disease. The plasma samples were measured for retinol, ,Bcarotene and vitamin E using high pressure liquid chromatography as described for retinol assay (Vuilleumier et al., 1983) . This was done in ignorance of their source (cases or controls).
Results
The mean plasma retinol, #-carotene and vitamin E levels in cases and controls are shown in Table I 
Discussion
In this study, plasma retinol levels were not related to subsequent risk of breast cancer, whereas plasma vitamin E levels showed a clear association (low levels being associated with a significantly higher risk of cancer). f-carotene levels showed a similar tendency, but the effect was less strong and less consistent.
The relationship between low plasma vitamin E and #-carotene and a high incidence of breast cancer may be a direct effect of these micronutrients or may be due to other factors which are themselves associated with vitamin E and fl-carotene. The mean interval between sample collection and diagnosis of breast cancer was 5 Vitamin E, 0.1-, 3.3-, 4.6-, 5.9-, 7.7-17.5mg1I.
years. For all but 6 cases the interval was 2 or more years. The long interval between the time when the blood samples were collected and when breast cancer was diagnosed (5-years on average) makes it unlikely that the cancer caused the lower levels of these micronutrients. Similar results were found after excluding women who were diagnosed within 2 years of the blood sample being collected. After such exclusions the standardised mean vitamin E level for cases was 4.4 mg 11 compared with 5.9mgI-1 for controls (P<O.O1), and the corresponding values for fl-carotene were 29 jugland 50pgI1-.
Plasma fl-carotene levels are known to be associated with diet, particularly the consumption of vegetables. The determinants of plasma vitamin E are less well known, but appear to include dietary factors. Vitamin E is present in many plants including lettuce, grasses, peanuts and seeds, the highest levels being associated with seed oil. Whatever the precise role of f-carotene or vitamin E in the aetiology of breast cancer, these findings may provide clues which help identify causes of breast cancer and thereby provide an opportunity of exploring ways of preventing the disease.
